Sumatriptan Succinate
35 NDCs across 9 manufacturers|33 Generic,2 Brand
Sumatriptan Succinate is used to treat cluster headache and migraine disorders, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 28, 1992, and the first generic was approved Feb 6, 2009. FDA's Orange Book lists 34 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $46 million on Sumatriptan Succinate across 1.9 million claims for 480,000 beneficiaries.
Sumatriptan Succinate is available as 35 NDCs from 9 manufacturers (33 generic, 2 brand), with NADAC prices from $0.24 to $0.44 per EA — a 83% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
35
33G / 2B
Manufacturers
9
competing in market
Price Spread
$0.24 – $0.44
per EA, 27 of 35 NDCs
7d Activity
avg -0.6% WoW · of 35 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Dr. Reddy's Laboratories Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
9 manufacturers producing SUMATRIPTAN SUCCINATE(2 pricing outliers)
Frequently Asked Questions
What is Sumatriptan Succinate used to treat?
Sumatriptan Succinate is used to treat cluster headache and migraine disorders, per the National Library of Medicine's MED-RT classification.
When did Sumatriptan Succinate become available as a generic?
FDA approved the first generic Sumatriptan Succinate (ANDA) on Feb 6, 2009. The Orange Book currently lists 34 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Sumatriptan Succinate?
In 2024, Medicare Part D spent $46 million on Sumatriptan Succinate across 1.9 million claims for 480,000 beneficiaries.
How many Sumatriptan Succinate products are on the market?
The Sumatriptan Succinate drug market contains 35 NDCs from 9 manufacturers — 33 generic and 2 brand products.
What is the price range for Sumatriptan Succinate?
NADAC reference prices for Sumatriptan Succinate range from $0.2394 to $0.4388 per EA — a 83% difference between cheapest and most expensive. 8 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Sumatriptan Succinate?
9 manufacturers list Sumatriptan Succinate in NADAC. Ranked by number of NDCs, the largest are Dr. Reddy's Laboratories Inc. (14), Sun Pharmaceutical Industries Inc. (7), NorthStar Rx LLC (4), Mylan Pharmaceuticals Inc. (3), Aurobindo Pharma Limited (3).
How has the price of Sumatriptan Succinate changed recently?
Over the past 7 days, 16 Sumatriptan Succinate NDCs rose and 11 fell, with a market-wide average change of -0.6%.